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SUMMARY
Breaching endothelial cells (ECs) is a decisive step in
the migration of leukocytes from the vascular lumen
to the extravascular tissue, but fundamental aspects
of this response remain largely unknown. We have
previously shown that neutrophils can exhibit ablu-
minal-to-luminal migration through EC junctions
within mouse cremasteric venules and that this
response is elicited following reduced expression
and/or functionality of the EC junctional adhesion
molecule-C (JAM-C). Here we demonstrate that the
lipid chemoattractant leukotriene B4 (LTB4) was effi-
cacious at causing loss of venular JAM-C and pro-
moting neutrophil reverse transendothelial cell
migration (rTEM) in vivo. Local proteolytic cleavage
of EC JAM-C by neutrophil elastase (NE) drove this
cascade of events as supported by presentation of
NE to JAM-C via the neutrophil adhesion molecule
Mac-1. The results identify local LTB4-NE axis as a
promoter of neutrophil rTEM and provide evidence
that this pathway can propagate a local sterile in-
flammatory response to become systemic.
INTRODUCTION
Neutrophil infiltration into interstitial tissues is a critical compo-
nent of the innate immune response and a hallmark of acute
inflammatory reactions. Due to the destructive potential of
neutrophils, this response is also intimately associated with
the pathogenesis of numerous inflammatory conditions such
as ischemia-reperfusion (I-R) injury, rheumatoid arthritis, and
atherosclerosis (Nathan, 2006; Phillipson and Kubes, 2011;
Mo´csai, 2013). Neutrophil migration out of the vasculature is
classically described by the leukocyte adhesion cascade that
depicts a well characterized sequence of cellular and molecular
events within the vascular lumen as orchestrated by numerous
stimulatory and adhesive pathways (Ley et al., 2007). Less is
known about the stages beyond the vascular lumen, though
there is a growing understanding of the adhesive interactions
that mediate neutrophil interactions with components of venular
walls (Ley et al., 2007; Nourshargh et al., 2010; Proebstl et al.,
2012; Nourshargh and Alon, 2014) and themolecular and cellular
regulation of neutrophil motility in the interstitial tissue (La¨mmer-
mann et al., 2013; Weninger et al., 2014).
The migration of neutrophils through the endothelial cell (EC)
barrier can occur via both paracellular and transcellular modes
(Nourshargh et al., 2010; Kolaczkowska and Kubes, 2013)
though the former is considered to be the most prevalent in the
peripheral circulation (Schulte et al., 2011; Woodfin et al.,
2011). This response is known to be mediated by numerous
EC junctional molecules including platelet endothelial cell adhe-
sionmolecule-1 (PECAM-1), members of the junctional adhesion
molecule (JAM) family, ICAM-2, VE-cadherin, and CD99 (Nour-
shargh et al., 2010; Voisin and Nourshargh, 2013; Vestweber
et al., 2014). In addition to moving from the vascular lumen to
the extravascular tissue, there is now unequivocal evidence for
the ability of neutrophils to exhibit reverse motility through the
endothelium. Specifically, through the application of a high res-
olution confocal intravital microscopy (IVM) platform to analysis
of leukocyte transmigration in the mouse cremaster muscle,
we have noted that neutrophils can exhibit migration through
EC junctions in an abluminal-to-luminal direction (Woodfin
et al., 2011). This neutrophil rTEM response is most prevalent
in tissues subjected to the sterile injury caused by I-R, an inflam-
matory insult that is associated with reduced expression of
JAM-C at EC junctions (Scheiermann et al., 2009; Woodfin
et al., 2011). Furthermore, pharmacological blockade or genetic
deletion of EC JAM-C enhances the frequency of neutrophil
rTEM through cremasteric venules (Woodfin et al., 2011) and
blockade of EC JAM-C has been shown to promote monocyte
rTEM through cultured human umbilical vein ECs (HUVECs)
(Bradfield et al., 2007). Together, these results have identified
EC junctional JAM-C as a regulator of polarized movement of
leukocytes from the vascular lumen toward the sub-EC space.
While the phenomenon of neutrophil rTEM has been illustrated
using in vitro models of neutrophil TEM (Buckley et al., 2006)
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Figure 1. LTB4 Mediates I-R Induced Loss of EC JAM-C
(A) Confocal images of mouse cremasteric venules in control or I-R stimulated tissues immunostained for MRP14 (neutrophils), VE-cadherin, and JAM-C. Images
are representative of three independent experiments.
(legend continued on next page)
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and subsequently in vivo within zebrafish embryos (Mathias
et al., 2006), our findings within the mouse cremaster muscle
provide direct evidence for neutrophil rTEM within a mammalian
system, urging a need for better understanding of this unex-
pected response (Woodfin et al., 2011).
To acquire a greater insight into the frequency, regulation, and
pathophysiological role of neutrophil rTEM here, we sought to
identify the inflammatory trigger(s) that promote neutrophil
rTEM in response to I-R. Specifically, because reduced expres-
sion and/or functionality of EC JAM-C was instrumental in pro-
moting neutrophil rTEM in vivo, we investigated the mechanism
through which EC JAM-C was lost at sites of sterile injury. The
results identified endogenous leukotriene B4 (LTB4) as the
mediator responsible for I-R-elicited loss of venular JAM-C and
showed that exogenous LTB4 was highly efficacious at lowering
the expression of EC JAM-C in vivo. This effect was neutrophil-
dependent, with neutrophil elastase (NE) governing the cleavage
of EC JAM-C at sites of intense neutrophil infiltration. Further-
more, local LTB4 and NE could both promote notable neutrophil
rTEM. Although investigations into the pathophysiological rele-
vance of neutrophil rTEM are at a developing stage, our previous
findings suggested an association between neutrophil rTEM and
distant organ inflammation (Woodfin et al., 2011). In line with this
possibility, here we show that activation of LTB4–NE axis can
drive a local inflammatory response to become a systemic
multi-organ reaction, providing further evidence for an associa-
tion between occurrence of neutrophil rTEM and development
of secondary organ inflammation.
RESULTS
Endogenously Generated LTB4 Accounts for Reduced
Expression of Local EC JAM-C in Response to I-R
The mechanism of EC JAM-C reduction was investigated in a
murine model of cremaster muscle I-R (30 min ischemia, 2 hr
reperfusion), an injury model that is amenable to rapid and
high-resolution intravital microscopy (Woodfin et al., 2011).
This sterile injury model is characterized by profound local
neutrophil infiltration and is associated with increased fre-
quency of neutrophil rTEM (Figures 1A–1D; Movie S1) (Woodfin
et al., 2011). Elevated percentages of neutrophil rTEM were
also observed in cremaster muscles injected with lipopolysac-
charide (LPS) (26.4% of all TEM events, n = 6 mice, p = 0.040),
identifying local endotoxemia as another inflammatory reaction
in which neutrophil rTEM can occur. Since I-R-induced neutro-
phil rTEM was closely linked with loss of JAM-C from venular
EC junctions (Figures 1A and 1E), to determine the mediator(s)
that caused this effect, dissected control and I-R stimulated tis-
sues were analyzed by protein array and ELISA. This approach
identified numerous inflammatory mediators generated locally
in response to I-R, including a number of cytokines (e.g.,
IL-1b, IL-1a, IL-6), chemokines (MIP-2, KC), C5a, and the lipid
mediator LTB4 (Figure S1A; Figures 1F and 1G). To investigate
the impact of these mediators on expression of EC JAM-C
in vivo, we injected the stimuli locally into mouse ear skin or
cremaster muscles and analyzed the tissues by immunofluo-
rescent staining and confocal microscopy. Based on prelimi-
nary studies, a number of these stimuli were analyzed in detail.
These included the neutrophil chemoattractants C5a, MIP-2,
KC, and LTB4, mediators that were tested at doses that
induced comparable neutrophil infiltration (Figure 1H). While
intradermal C5a, MIP-2 and KC had no impact on EC JAM-C
expression in skin, LTB4 reduced JAM-C expression on post-
capillary venules (Figures 1H and 1I). LTB4, but not KC, also
reduced the expression of EC JAM-C in cremasteric venules
(Figure 1J). Locally administered LTB4 had no impact on protein
expression or localization of other key EC junctional molecules
such as PECAM-1, VE-cadherin, or JAM-A (Figure 1H; Figures
S1B and S1C). The functional importance of endogenously
generated LTB4 in the cremaster I-R model was confirmed
using the LTB4 BLT1 receptor antagonist LY293111. Animals
pre-treated systemically (intravenously, i.v.) with LY293111
showed significant reduction of local neutrophil infiltration (Fig-
ure 1K) but were totally protected from loss of EC JAM-C
following I-R (Figure 1L). Collectively, these results show that
in response to mouse cremasteric I-R, reduced expression of
EC JAM-C is accounted for by endogenous LTB4 and that
exogenous LTB4 is efficacious at causing loss of EC JAM-C.
Furthermore, in agreement with our model that reduced func-
tionality of EC JAM-C drives neutrophil rTEM, at doses that
induced comparable neutrophil infiltration, local LTB4 but not
KC promoted neutrophil rTEM (Figure 1M; Movie S2).
(B) Quantification of transmigrated neutrophils (n = 3–6) and (C) frequency of neutrophil rTEM events (77–72 events, n = 3–7 mice) through mouse cremasteric
venules of tissues subjected to I-R or sham operated, involving 14 independent experiments.
(D) Time-lapse images of a movie (Movie S1) tracking the rTEM response of a GFP-labeled neutrophil (green) through a venule labeled with anti-PECAM-1 mAb
(red) following cremaster I-R. On the left are video micrographs of a venular segment imaged from the luminal side that show a neutrophil (arrow head) in the
sub-EC space (t = 2 min) that subsequently re-enters the vascular lumen (from 5 min onward) and eventually crawls back into the circulation (13 min). Right side
panels show corresponding transverse sections of selected images.
(E) Quantification of junctional EC JAM-C expression acquired from images as shown in (A) (n = 3–6). Images are representative of three independent
experiments.
(F and G) Inflammatory mediators in homogenated sham and I-R stimulated cremasters as measured by protein array (F) or ELISA (G) (n = 3).
(H) Confocal images of mouse ear skin injected locally (4 hr, i.d.) with the indicated stimuli and immunostained for MRP14, VE-cadherin, and JAM-C. Images are
representative of five independent experiments.
(I and J) Quantification of junctional EC JAM-C expression in ears (I, from images as in H) or cremasters (J) of control tissues or tissues injected locally with the
indicated stimuli, as analyzed by confocal microscopy (n = 4–6) from five independent experiments.
(K and L) Quantification of transmigrated neutrophils (K) and junctional EC JAM-C expression (L), as analyzed by confocal microscopy, in sham operated controls
or I-R injured cremasters in mice pretreated with vehicle or LY293111 (n = 3–5) involving three independent experiments.
(M) Frequency of neutrophil rTEM events in cremaster muscles injected locally with saline, LTB4 or KC (n = 73-129 events, 3–9 mice) involving 15 independent
experiments. Data indicate mean ± SEM or percentage of total events ± SEM (C and M). *p < 0.05, **p < 0.01 and ***p < 0.001 as compared to controls and
#p < 0.05, ##p < 0.01, ###p < 0.001 as indicated by lines. Scale bars represent 20 mm (A and H) and 10 mm (D). See also Figure S1 and Movies S1 and S2.
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LTB4-Induced Loss of EC JAM-C Is Neutrophil
Dependent
Loss of EC JAM-C caused by locally administered LTB4
occurred in a dose- and time-dependent manner (Figures 2A
and 2B). Significant reduction in expression of EC JAM-C at
EC junctions was noted as early as 30mins post local application
of LTB4 (Figure 2B). This was sustained for up to 8 hr and re-
turned to normal by 24 hr (Figure 2B). Of note, total expression
of venular EC JAM-C (i.e., including junctional and cell body
expression) was also significantly reduced post administration
of LTB4, but with a slight temporal delay as compared to junc-
tional JAM-C (Figures 2B and 2C). These results suggest that
EC JAM-C is initially re-localized from junctions to non-junctional
regions (e.g., plasma membrane) following LTB4 stimulation, in
agreement with our findings using the mouse cremaster I-R
model (Scheiermann et al., 2009). This response might then be
followed by total loss of the protein at later time points.
The time-course of LTB4-induced loss of venular JAM-C was
directly aligned with time-course of LTB4-elicited neutrophil
attachment to and migration through venular walls (Figures 2D
and 2E). In addition, while JAM-C was expressed in all types of
microvessels (capillaries > venules > arteries in ear skin and
cremaster muscle; Figure S2), in LTB4-stimulated tissues,
reduced expression of the molecule was selectively noted in
post-capillary venules, the primary sites of neutrophil transmi-
gration. Indeed, in tissues stimulated with locally administered
LTB4, reduced expression of EC JAM-C was a feature of ven-
ular segments supporting intense neutrophil transmigration
(‘‘hot-spots’’) (Figures 2F and 2G). Collectively, these results
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Figure 2. LTB4-Induced Loss of EC JAM-C Is
Neutrophil Dependent
(A) Dose response of LTB4-mediated reduced
expression of EC JAM-C in ear skin of WT mice as
analyzed by confocal microscopy (n = 4) from eight
independent experiments.
(B–E) Time course of LTB4-mediated reduced
expression of junctional (B) or total (C) EC JAM-C,
neutrophil adhesion (luminal) (D), and neutrophil
transmigration (E) in ears, as analyzed by confocal
microscopy (n = 4–8) involving 23 independent
experiments.
(F and G) Confocal images depicting ‘‘hot spots’’
of neutrophil (MRP14+) transmigration in micro-
vessels (VE-cadherin) of LTB4-stimulated ears. (G)
High magnification of the labeled (i–v) venular
segments indicated in (F). The lower panels indi-
cate the associated mean fluorescence intensities
(MFI) of EC JAM-C junctional expression.
(H) Quantification of junctional EC JAM-C expres-
sion in unstimulated or LTB4-stimulated ears in
control and neutrophil-depleted mice (n = 3–7)
involving four independent experiments. Data
indicate mean ± SEM. *p < 0.05, **p < 0.01 and
***p < 0.001, as compared to controls and #p < 0.05
as indicated by lines. Scale bars represent 100 mm
(F) and 20 mm (G). See also Figure S2.
suggested a role for neutrophils in loss
of EC JAM-C. Direct evidence for this
was obtained through the use of mice
depleted of their circulating neutrophils
in which LTB4-injected tissues (skin) showed normal expression
of venular JAM-C (Figure 2H), contrary to the reduced amounts
noted in LTB4-stimulated control mice. These results indicate
that loss of EC JAM-C following LTB4 stimulation is a neutro-
phil-dependent phenomenon and implied proteolytic cleavage
of the protein as a possible mechanism.
Neutrophil Elastase Cleaves EC JAM-C
Because LTB4 is a potent inducer of NE release and/or cell-sur-
face expression (Rainger et al., 1998; Young et al., 2007), we
considered that this serine protease might cleave EC JAM-C in
response to LTB4. Initial in vitro studies using an anti-NE mAb
and an NE-fluorescent activatable substrate (NE680FAST) illus-
trated the potent ability of LTB4 to rapidly mobilize intracellular
stores of NE protein and to increase NE activity, respectively,
to the neutrophil cell surface (Figures 3A–3C). Such effects
were not noted with C5a or KC. Importantly, mobilization of
neutrophil intracellular stores of NE protein and intense neutro-
phil-associated NE activity could also be observed in vivo in
LTB4-stimulated tissues as compared to tissues stimulated by
other inflammatory mediators (Figures 3D and 3E). The use of
Elane/ (NE/) mice or the NE inhibitor GW311616A provided
conclusive in vivo evidence for the involvement of NE in JAM-C
cleavage (Figure 3F; Figure S3). Furthermore, purified NE
cleaved recombinant soluble JAM-C in vitro, as shown by immu-
noblot (Figure 3G). Collectively, these results demonstrate that
neutrophil-derived NE is responsible for loss of EC JAM-C as
induced following rapidmobilization of the enzyme to the neutro-
phil cell surface by LTB4.
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Binding of NE to Mac-1 Supports Cleavage of JAM-C
We next sought to investigate the impact of exogenously admin-
istered NE on EC JAM-C in vivo. In contrast to the in vitro ability
of NE to cleave JAM-C, local injection of NE into cremaster
muscles failed to impact the expression of EC JAM-C (Figure 4A).
This discrepancy was considered to be due to an essential need
for neutrophils in vivo, because exogenous NE failed to signifi-
cantly induce neutrophil transmigration (Figure 4B). Specifically,
we hypothesized that neutrophils might be required to present
NE to JAM-C on ECs in order for NE to cleave this adhesion
molecule. To explore this possibility, we co-injected NE with
KC, a chemokine that induced significant neutrophil infiltration
but at the dose tested had no impact on EC JAM-C expression
(Figures 4A and 4B). Cremaster muscles co-injected locally
with NE and KC showed similar neutrophil infiltration to that
noted with KC alone (Figure 4B). However, in contrast to tissues
injected with KC or NE alone, tissues stimulated with NE+KC
exhibited a significant reduction in EC JAM-C expression (Fig-
ure 4A). Because NE has previously been reported to bind to
the neutrophil integrin Mac-1 (Cai and Wright, 1996) and
Mac-1 is a ligand for JAM-C (Santoso et al., 2002), we consid-
ered that the underlying reason for the efficacy of LTB4 to induce
cleavage of JAM-C might be due to the ability of the lipid to be
both an effective activator of Mac-1 and inducer of NE release.
In support of this, mouse neutrophils stimulated with LTB4 or
KC adhered to ICAM-1-coated slides in a Mac-1-dependent
manner (Figure 4C), demonstrating activation of the integrin by
these neutrophil chemoattractants. Under these in vitro condi-
tions, however, at concentrations that caused comparable adhe-
sion to ICAM-1-coated slides, only LTB4 was capable of eliciting
release of NE (Figure 4D). The functional implication of this in
relation to JAM-C cleavage was investigated in an assay inwhich
the interaction of neutrophils with JAM-C and ICAM-1-coated
slides was analyzed by fluorescent microscopy and JAM-C
cleavage was quantified through immunofluorescence detection
of JAM-C (Figures 4E–4H). Stimulation of cells with LTB4 or KC
again induced comparable neutrophil adhesion to the coated
slides (as found with ICAM-1-coated slides), but only LTB4 stim-
ulation significantly increased cleavage of JAM-C as compared
to unstimulated control cells (Figures 4E–4I). The latter response
was NE dependent, as assessed using an NE inhibitor
(GW311616A) (Figure 4I). This assay was next extended to
explore the possibility that direct interaction of Mac-1 with NE
is necessary for cleavage of JAM-C. For this purpose, Elane/
neutrophils were pre-treated with or without anti-Mac-1 mAb
followed by LTB4 stimulation in the presence of exogenous NE
(Figure 4J). The resulting cell samples were then washed and
placed onto JAM-C- and ICAM-1-coated slides, and after
30 min the slides were fixed and stained for JAM-C expression.
In this model, LTB4-stimulated Elane
/ cells supplemented with
exogenous NE led to JAM-C cleavage, and this response was
totally inhibited under conditions of Mac-1 blockade (Figure 4K).
Finally, co-immunoprecipitation experiments showed that
Mac-1 from LTB4-stimulated (but not control unstimulated)
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Figure 3. Neutrophil Elastase Mediates
Cleavage of EC JAM-C
(A–C) Effect of LTB4, as compared to other indi-
cated stimuli, on cell surface NE protein expres-
sion (using an anti-NE mAb) (A and B, n = 32–102
cells) and NE activity (C, n = 23–166 cells) of BM
neutrophils adherent to BSA-coated slides. Data
are representative of three independent experi-
ments.
(D) Confocal images of stimulated cremaster
muscles immunofluorescently stained for NE,
neutrophils (MRP14), and VE-cadherin showing
re-distribution of NE to the cell surface following
1 hr tissue stimulation with LTB4 but not KC (n = 2
mice per group). Images are representative of two
independent experiments.
(E) Confocal images showing NE activity (white) in
ears injected intradermally with the indicated
stimuli. Venules are shown in red (VE-cadherin)
(n = 3 mice per group). Images are representative
of two independent experiments.
(F) Quantification of EC JAM-C expression in
control and LTB4-stimulated ears of WT and
Elane/ mice (n = 5–9) from four independent
experiments.
(G) Immunoblot against JAM-C shows the ability of
purified NE to cleave recombinant JAM-C (repre-
sentative of three independent experiments). Data
indicate mean ± SEM. ***p < 0.001, as compared
to control and ###p < 0.001 as indicated by lines.
Scale bars represent 5 mm (B, bottom panels) and
20 mm (B, upper panels; D and E). See also
Figure S3.
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Figure 4. NE Bound to Mac-1 Mediates Cleavage of JAM-C
(A andB) Quantification of EC JAM-C expression (A) and number of transmigrated neutrophils (B) in cremastermuscles locally injected (4 hr, i.s.) with the indicated
stimuli (n = 3–6) involving four independent experiments.
(C and D) Neutrophil adhesion to ICAM-1-coated slides (C) (n = 3 experiments) and NE activity (D) (n = 5 experiments) as induced by LTB4 and KC.
(E–H) Unstimulated (control), LTB4- and KC-stimulated neutrophils (MRP-14; red) adherent to slides co-coated with ICAM-1 and JAM-C (green) (E) and asso-
ciated regions of JAM-C loss (F). Bottom panels (G) show high-magnification images of the boxed regions in (F) with the associated linear intensity profiles (H) of
the neutrophil (red) and JAM-C (green) channels along the white dotted lines (G). Black dotted lines in (H) indicate average expression of JAM-C at sites of
neutrophil adhesion in control unstimulated samples.
(I) Quantification of JAM-C at sites of neutrophil adhesion as illustrated in (E)–(H) (n = 4 experiments).
(J and K) Protocol (J) used for quantification (K) of JAM-C expression post adhesion of LTB4-stimulated Elane
/ neutrophils to JAM-C- and ICAM-1-coated
slides (n = 3 experiments).
(L) Co-immunoprecipitation and immunoblot analysis of untreated and LTB4-stimulated neutrophils (representative of two independent experiments). Data
indicate mean ± SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 as compared to controls and ##p < 0.01, ###p < 0.001 as indicated by lines. Scale bars represent 10 mm.
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mouse neutrophils binds to both NE and JAM-C (Figure 4L).
Collectively, these results further illustrated the importance of
NE in JAM-C cleavage and demonstrated that NE bound to
neutrophil Mac-1 supported this response.
Local LTB4-NE Axis Promotes Neutrophil rTEM
Because LTB4 andNEwere identified as keymolecular players in
inducing loss of EC JAM-C and we have previously shown that
reduced expression of EC JAM-Cdrives neutrophil rTEM (Wood-
fin et al., 2011), we next explored the role of the LTB4-NE axis in
induction of neutrophil rTEM. LTB4-induced neutrophil rTEMwas
significantly suppressed in Elane/ mice and in wild-type (WT)
mice pre-treated with an NE inhibitor (Figure 5A). In addition,
because KC, a mediator that did not impact the expression of
EC JAM-C (Figure 1H–1J), also failed to elicit a notable frequency
of neutrophil rTEM (Figure 1M), the effect of the chemokine when
co-injected with NE into the cremaster muscle (a reaction that
caused local loss of EC JAM-C; Figure 4A) was tested. This reac-
tion led to profound frequency of neutrophil rTEM as compared
to responses detected inmice injectedwith KC alone (Figure 5B).
Collectively, the results demonstrate that locally activated
LTB4-NE axis is highly effective at promoting neutrophil rTEM.
Activation of LTB4-NE Axis Drives a Local Inflammatory
Response to Become Systemic
We have previously found an association between loss of EC
JAM-C expression and/or functionality, neutrophil rTEM, and
distant organ (lung) inflammation (Woodfin et al., 2011). Having
identified LTB4 as an effective stimulus that triggers NE-medi-
ated loss of EC JAM-C and promoted neutrophil rTEM, we inves-
tigated a possible causal relationship between this cascade of
events and secondary organ inflammation. In addition to stimu-
lating local neutrophil infiltration (Figure 6A), LTB4 injected into
the mouse cremaster muscle elicited neutrophil accumulation
into lungs (Figure 6B) and tissue damage (plasma protein
leakage) inmultiple organs, e.g., lung, heart, and liver (Figure 6C).
Time-course studies illustrated that, after injection of LTB4 into
the mouse cremaster muscle, lung injury peaked at 4 hr and re-
turned to normal by 24 hr (Figure S4A). A similar transient profile
of lung injury was found in other tissues such as the heart (Fig-
ure S4B). Similarly to the cremaster muscle, intradermal injection
of LTB4 into the ear skin promoted lung neutrophil accumulation
(Figure S4C) and remote organ damage (Figure S4D). These
effects were attenuated in Elane/ mice or in WT mice pre-
treated with the NE inhibitor GW311616A (Figures 6B–6D; Fig-
ure S4D), without affecting local LTB4-induced neutrophil
recruitment (Figure 6A). Of note, Elane/mice andWTmice pre-
treated with GW311616A exhibited normal neutrophil migration
into lungs in response to intranasal instillation of LTB4 (Fig-
ure S4E), indicating that NE blockade does not directly suppress
neutrophil infiltration into lungs. Together these results show that
LTB4, when administered into a primary tissue site, can promote
secondary organ damage in an NE-dependent manner. Impor-
tantly, we also noted increased remote organ (lung and heart)
damage following cremaster I-R injury, a response that was in-
hibited in Elane/ mice (Figure S4F).
Because NE was found to be essential in regulating LTB4-
induced local EC JAM-C expression (Figure 3F; Figure S3), a
potential link between local loss of EC JAM-C and secondary
organ inflammation was further investigated. For this purpose,
we analyzed the effects of locally administered KC, a neutrophil
chemoattractant that did not cause loss of EC JAM-C (Figures
1H–1J). When applied locally to the cremaster muscle at a dose
that elicited significant local neutrophil infiltration (Figure 4B),
KC did not cause neutrophil recruitment into lungs (Figure 6E).
In contrast, while the combined injection of KC and NE into the
cremaster muscle induced comparable neutrophil infiltration to
that observedwith KCalone (Figure 4B), KC+NE led to significant
neutrophil accumulation into lungs, as compared to responses
detected in mice treated with KC or NE alone (Figure 6E).
Because we have previously shown that KC+NE can cause local
loss of EC JAM-C and promote neutrophil rTEM (Figure 4A and
5B), these results provide strong evidence to suggest that local
regulation of EC JAM-C is instrumental in promoting distant
organ damage. In support of this, we noted that KC, when in-
jected into the cremaster muscle of mice with specific deletion
of EC JAM-C (Tekcre;Jam-3flox/flox), caused significant lung
edemaas compared to responsesobserved in littermate controls
(Figure 6F). Collectively, through loss-of-function and gain-of-
function studies, these results demonstrate that inflammatory re-
actions that canmediate NE-induced local loss of EC JAM-C can
promote development of secondary multi-organ inflammation.
Soluble JAM-C IsDetected in Plasma of Locally Inflamed
Mice and in Trauma Patients
As a consequence of local proteolytic cleavage by NE, we spec-
ulated that soluble JAM-C (sJAM-C) might be detectable in
plasma of mice after tissue stimulation. The low circulating
sJAM-C detected in control mice was significantly increased
following intradermal injection of LTB4 (Figure 7A), a parameter
that inversely correlated with the loss of venular EC JAM-C (p =
0.0041). This response was abrogated in Elane/ mice and in
A B
Figure 5. LTB4 and NE Promote Neutrophil rTEM
Frequency of neutrophil rTEM events through cremasteric venules of tissues
from WT mice injected locally with saline (control) or LTB4 with or without pre-
treatment with GW311616A and in Elane/mice injected with LTB4 (A) and in
tissues injected locally with KC or KC+NE (B) (19–217 events, 3–9 mice)
involving 22 independent experiments. Data indicate percentage of total
events ± SEM. **p < 0.01 as compared to controls and #p < 0.05 and ##p < 0.01
as indicated by lines.
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mice depleted of their circulating neutrophils (Figure 7A), illus-
trating that as found with local loss of venular EC JAM-C, pres-
ence of sJAM-C in plasma is both neutrophil- and NE-depen-
dent. Importantly, elevated sJAM-C was also found in plasma
samples from trauma patients as compared to control volunteers
(Figure 7B). Patients who developed acute respiratory distress
syndrome (ARDS) exhibited higher amounts (>50%) of plasma
sJAM-C on admission than those who maintained normal lung
function (Figure 7B). Furthermore, therewas a significant correla-
tion between on admission plasma content of sJAM-C and the
subsequent severity of multi-organ failure (MOF) as assessed
by their Sequential Organ Failure Assessment (SOFA) scores at
48 hr after injury (Figure 7C). Thus, in conjunction with our previ-
ous findings, there is an association between increased amounts
of sJAM-C in plasma and distant organ inflammation following
local LTB4 in mice and importantly post tissue injury in humans.
DISCUSSION
Here we investigated the mechanism through which neutrophil
rTEM is triggered in vivo. The results identified the lipid neutrophil
chemoattractant LTB4 as a key mediator capable of promoting
proteolytic cleavage of EC JAM-C by NE, a response that drives
neutrophil rTEM. The activation of this cascade of events was
also associated with dissemination of systemic inflammation,
suggesting that targeting LTB4-NE axis might be an efficacious
means of suppressing secondary organ damage following local
inflammation or injury.
While neutrophils play a key role in mounting an early innate
immune response and have also been intimately associated
with the development of acute inflammatory disorders, there is
now ample evidence for a broader role for neutrophils in inflam-
mation and immunity (Mantovani et al., 2011; Mo´csai, 2013;
Mayadas et al., 2014). Most notably, neutrophils are known to
interact with components of the adaptive immune response
and have been implicated in the pathogenesis of numerous
chronic inflammatory conditions (Mantovani et al., 2011; Mo´csai,
2013; Mayadas et al., 2014). Furthermore, the traditional view of
neutrophils exhibiting a short half-life (i.e., < several hours) has
been challenged (Tak et al., 2013), and there is evidence for
the existence of neutrophil ‘‘subsets’’ exhibiting a wide range
of phenotypes in different physiological and pathological condi-
tions (Beyrau et al., 2012; Kolaczkowska and Kubes, 2013). In
addition, while conventionally neutrophils have been considered
as cells that move in a one-way direction, there is now evidence
for the ability of neutrophils to breach ECs in an abluminal-to-
luminal direction, i.e., exhibit reverse TEM (Buckley et al.,
2006; Mathias et al., 2006; Woodfin et al., 2011), though our
understanding of the prevalence, regulation, and implications
of this response are at an early stage.
Through the application of confocal IVM to analysis of in-
flamed mouse cremaster muscles, we recently reported signifi-
cant frequency of neutrophil rTEM following I-R (Woodfin et al.,
2011). Mechanistically, rTEM was associated with and indeed
promoted by reduced expression and/or function of EC JAM-C
(Woodfin et al., 2011). To gain a better understanding of the in-
flammatory trigger(s) that promote neutrophil rTEM, we sought
to identify the mechanism(s) through which EC JAM-C is lost.
Analysis of mouse cremaster muscles subjected to I-R detected
an array of endogenously generated mediators, in line with the
network of mediators identified in other models of I-R (Iadecola
and Anrather, 2011; Smith et al., 2012). Among these, LTB4
was identified as a mediator that effectively reduced expression
of EC JAM-C in vivo, and through the use of a specific BLT1
A B C
D E F
Figure 6. LTB4 andNEPromoteDistantOrgan
Damage
(A) Quantification of transmigrated neutrophils into
mouse cremaster muscles in unstimulated tissues
(control) or 4 hr post local injection of LTB4 with
or without pretreatment (24 hr) of mice with
GW311616A (n = 4–7) from six independent experi-
ments.
(B) Quantification of lung neutrophil numbers (n =
4–15) following cremaster stimulation (as in A)
involving 15 independent experiments.
(C) Quantification of lung, heart, and liver albumin
content (plasma extravasation), as amarker of tissue
damage, following local (cremaster) injection of LTB4
(4 hr) as compared to control unstimulated tissues in
WT and Elane/ mice (n = 4–24) involving 12 inde-
pendent experiments.
(D) Lung albumin content in unstimulated tissues
(control) or post local (cremaster) injection of LTB4
with or without pretreatment (24 hr) of mice with
GW311616A (n = 4–24) involving 16 independent
experiments.
(E and F) Lung neutrophil numbers (E) (n = 6–15) and
tissue albumin content (F) (n = 3–5) following local
injection of KC, NE, or KC+NE in cremaster muscles
of WT or Tekcre;Jam-3flox/flox mice involving 21 in-
dependent experiments. Data indicate mean ± SEM.
*p < 0.05, **p < 0.01 and ***p < 0.001 as compared to
controls and #p < 0.05 and ##p < 0.01 as indicated by
lines. See also Figure S4.
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receptor antagonist, endogenous LTB4 was found to be totally
accountable for loss of EC JAM-C expression in response to
I-R. In agreement with investigations of other disease models
(Souza et al., 2000; Kim et al., 2006; Chou et al., 2010), LTB4
also contributed to local neutrophil infiltration as elicited by I-R.
An important cellular source of this LTB4 is likely to be the neu-
trophils themselves (Chen et al., 2006; Afonso et al., 2012; La¨m-
mermann et al., 2013). The potent ability of locally administered
LTB4 to cause loss of EC JAM-C was associated with the ability
of this mediator to induce neutrophil rTEM. These results are
directly in line with our previous findings (Woodfin et al., 2011)
and the overall hypothesis that loss of EC JAM-C is instrumental
in mediating neutrophil rTEM.
The effect of LTB4 was selective to JAM-C in that it had no
impact on expression of other key EC adhesion molecules. We
have previously reported that in response to I-R, EC JAM-C is
re-distributed from junctions and intracellular cytoplasmic vesi-
cles toward non-junctional plasma membrane (Scheiermann
et al., 2009). Similarly, our present findings suggest an initial
redistribution of the molecule away from EC junctions following
LTB4 stimulation, a response that could support adhesion of
neutrophils to the endothelium (Scheiermann et al., 2009).
Reduction of both junctional and total JAM-C expression at later
time points suggested that the protein was also cleaved from
ECs in this reaction, and multiple lines of evidence indicated
that this was a neutrophil-dependent response. This included
the following: (1) The response occurred largely in post-capillary
venules, the primary site of neutrophil transmigration, (2) the
time-course of the response was directly aligned with the
time-course of neutrophil adhesion and transmigration, (3) EC
JAM-C losswasmost notable at sites of intense neutrophil trans-
migration (‘‘hot-spots’’), and finally, (4) LTB4-induced loss of EC
JAM-C was abolished in neutrophil-depleted mice. In investi-
gating the mechanism through which neutrophils caused
reduced expression of EC JAM-C, we focused our attention on
the possible role of NE. This serine protease is expressed within
neutrophil azurophil granules and exhibits a broad substrate
specificity, including numerous cell-surface receptors and adhe-
sion molecules (Pham, 2006). Because LTB4 is highly efficacious
at inducing NE degranulation from mouse neutrophils in vitro
(Young et al., 2007), we hypothesized that NE might mediate
neutrophil-dependent loss of EC JAM-C. In support of this,
LTB4 showed high efficacy in promoting rapid NE release and/
or cell-surface expression and activity (as mobilized from intra-
cellular stores), both in vitro and in vivo, as compared to other
neutrophil chemoattractants. Furthermore, we have recently
demonstrated that local LTB4 can rapidly activate neutrophils
within the vascular lumen when the neutrophils are in close
apposition to the venular wall and junctions (Finsterbusch
et al., 2014). Direct evidence for the role of NE in mediating
LTB4-induced loss of venular JAM-C was provided with the
use of NE-deficientmice ormice pre-treated with anNE inhibitor.
Together, our findings identify the potent ability of LTB4 to induce
mobilization of NE to the neutrophil cell surface as a key factor in
the ability of this lipid mediator to cause loss of JAM-C at sites of
inflammation.
Activation of the neutrophil BLT1 receptor is efficiently linked
to signaling pathways that trigger degranulation of azurophil
granules containing NE (Rainger et al., 1998). This could be of
physiological benefit when LTB4 is generated and localized to
the interstitial tissue. Here it can support clearance of pathogens
or act as a signal-relay molecule for neutrophil chemotaxis or
neutrophil swarming to sites of injury, responses that have
been linked to NE and LTB4, respectively (Belaaouaj et al.,
1998; Afonso et al., 2012; La¨mmermann et al., 2013). In contrast,
under pathological conditions, such as that encountered
following I-R injury, excessive generation of LTB4 might activate
neutrophils within the vascular lumen, leading to inappropriate
and damaging release of NE at the vessel wall. Based on our
findings and proposed model, the latter could lead to cleavage
of EC JAM-C and development of rTEM. To achieve this effect,
we hypothesized that following its release from azurophil gran-
ules, neutrophil surface-bound NE is presented to EC JAM-C
during TEM. The concept that serine proteases remain cell
bound after fusion of granules with the plasma membrane is
well recognized and is considered as a means through which
the enzymes are protected from endogenous interstitial protease
inhibitors (Owen and Campbell, 1999). What is less clear, how-
ever, is the mechanism through which serine proteases bind to
the neutrophil cell surface. In this context while charge-depen-
dent mechanisms have been proposed (Campbell and Owen,
2007), NE has also been shown to interact with neutrophil
Mac-1 (Cai and Wright, 1996). Building on these findings and
the fact that Mac-1 has been identified as a ligand for JAM-C
(Santoso et al., 2002), we extended our hypothesis to a potential
role for an LTB4-NE-Mac-1 axis in cleavage of JAM-C. Using a
number of in vitro models, our findings demonstrated that
although both LTB4 and KC could effectively induce Mac-1
A B C Figure 7. Locally Inflamed Mice and Trauma
Patients Exhibit Increased Plasma Content of
Soluble JAM-C
(A) Plasma sJAM-C in WT, Elane/, and neutrophil
depleted mice under basal conditions (control) and
following intradermal injection (ear, i.d. 4 hr) of LTB4
(n = 4–16) involving 11 independent experiments.
(B) Plasma content of sJAM-C in healthy control
volunteers and trauma patients with or without ARDS
(n = 8–10).
(C) Correlation of plasma sJAM-C with SOFA scores
in individuals from (B). Data indicate mean ± SEM.
*p < 0.05 and ***p < 0.001 as compared to controls.
Additional statistical analyses are indicated.
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activation, the efficacy of LTB4 to induce JAM-C cleavage re-
sides in the capacity of this mediator to induce NE expression
to the neutrophil cell surface. Taking advantage of NE deficient
neutrophils, evidence was obtained for the ability of NE to bind
to activated Mac-1 upon LTB4 stimulation, an interaction that
facilitated JAM-C cleavage. Importantly, rTEM caused by LTB4
was NE-dependent, and co-injection of exogenous NE with KC
(at doses that individually did not cause neutrophil rTEM)
induced profound rTEM, demonstrating that the activation of
the LTB4-NE axis (through loss-of-function or gain-of-function
studies) can lead to loss of EC JAM-C and promotion of neutro-
phil rTEM. Collectively, these findings provide support for the
overall hypothesis that NE is presented to EC JAM-C via acti-
vated Mac-1, the latter acting as a molecular ‘‘bridge’’ between
NE and JAM-C. This provides a mechanism through which
JAM-C is cleaved in a selective manner, thus promoting neutro-
phil rTEM.
At present, the functional implication of neutrophils under-
going reverse TEM is unclear. It is potentially possible that
this phenomenon might have a physiological role such as
dampening down a local inflammatory response (Mathias
et al., 2006; Yoo and Huttenlocher, 2011) and/or reflect a
role for neutrophils as cellular sentinels or sirens of inflamma-
tion. Alternatively, neutrophil rTEM might play a pathological
role such as contributing to turning a local acute inflammatory
response into a systemic phenomenon (Woodfin et al., 2011).
Although further studies are required, the results of the
present study support the latter. Most notably, local I-R injury
or local administration of LTB4 (cremaster muscle or ear skin)
caused remote organ damage. Furthermore, all pharmacolog-
ical or genetic interventions that suppressed or enhanced
neutrophil rTEM (e.g., Elane/ mice and NE+KC), corre-
spondingly regulated second organ inflammation. Because
neutrophils that have undergone rTEM have been shown to
exhibit a pro-inflammatory state (Buckley et al., 2006; Woodfin
et al., 2011), the present findings support the paradigm that
reverse TEM results in re-entry of a small subset of activated
neutrophils into the blood circulation that can contribute to
turning a local inflammatory response into a systemic phe-
nomenon. The findings further indicated that NE inhibition
had no impact on local neutrophil infiltration into the cremaster
muscle, suggesting that although NE is not essential in medi-
ating local neutrophil infiltration, excessive and/or inappropri-
ately generated local NE can promote neutrophil rTEM and
remote organ damage.
As a consequence of EC JAM-C cleavage by NE, increased
amounts of circulating sJAM-C were found in mice locally stim-
ulated with LTB4. Elevated concentration of sJAM-C was also
found in plasma from trauma patients as compared to healthy
controls, a parameter that further increased in patients that
developed acute respiratory distress syndrome (ARDS) after
admission. ARDS is characterized by severe respiratory failure,
and patients with ARDS exhibit 40% mortality rate (Rubenfeld
et al., 2005; Wheeler and Bernard, 2007). Pathophysiology of
ARDS is characterized by increased lung permeability and
neutrophil infiltration and is typically associated with sepsis
and multiple organ failure (MOF) (Matthay and Zemans, 2011).
Our findings, together with the reported elevated plasma content
of LTB4, as well as NE activity, found in trauma patients that
progress to ARDS (Donnelly et al., 1995; Auner et al., 2012),
suggest that similar mechanisms (i.e., LTB4-dependent NE
cleavage of EC JAM-C) could be taking place following
trauma. By extension, the results suggest that blocking JAM-
C cleavage by inhibition of NE could be a useful preventative
strategy in trauma patients at risk of developing ARDS and
MOF. Importantly, NE inhibitors are currently in use in Japan
in patients with ARDS associated with systemic inflammatory
response syndrome (SIRS), as well as for reducing surgery-
induced pulmonary inflammation (Fujii et al., 2010; Aikawa
et al., 2011). Together, the present study provides previously
unknown mechanistic insights into how NE inhibitors might
prevent secondary ARDS. Furthermore, because increased
plasma content of sJAM-C was associated with trauma-
induced organ failure and also elevated in serum or synovial
fluid from rheumatoid arthritis, psoriatic arthritis, osteoarthritis,
and systemic sclerosis patients (Rabquer et al., 2010; Manetti
et al., 2013), we propose that sJAM-C might be a useful
vascular-derived biomarker for assessing the extent of a sys-
temic inflammatory response.
In summary, we have identified a role for local LTB4 and NE as
regulators of neutrophil rTEM. Furthermore, although at present
the precise functional implications of neutrophils undergoing
rTEM remain unclear, the results of this study provide further
evidence for this phenomenon being associated with dissemina-
tion of inflammation.
EXPERIMENTAL PROCEDURES
Animals
Lyz2-EGFP-ki mice (exhibiting green fluorescent neutrophils), Elane/ mice,
Elane/-Lyz2-EGFP-ki mice, EC JAM-C/ mice (Tekcre;Jam-3flox/flox) and
their control littermates (Jam-3flox/flox), and wild-type C57BL/6 mice were
used. All animal experiments were conducted in accordance with the UK
Home Office legislations.
Patients
Blood from trauma patients (sampled less than 2 hr after injury) or healthy
donor controls was collected in buffered sodium citrate.
Induction of Inflammatory Reactions and Pre-treatments
Inflammatory stimuli such as LTB4, LPS, CXCL1 (KC), CXCL2 (MIP-2), C5a,
or vehicle control were injected in the ears or the cremaster muscles of
anesthetized mice. Some mice were pre-treated (24 hr, orally) with the NE
inhibitor GW311616A. Cremaster I-R injury (30 min ischemia followed by 2 hr
reperfusion) was induced as previously detailed (Scheiermann et al., 2009).
In some experiments, the LTB4 receptor antagonist LY293111 was adminis-
tered i.v. 15 min prior to I-R.
Whole-Mount Tissue Immunofluorescence Staining
Ears or cremaster muscles were immunostained before being mounted on
slides and analyzed by confocal microscopy.
Confocal Microscopy
Immunofluorescently stained cells and whole-mounted tissues were
imaged by confocal microscopy and analyzed by IMARIS or ImageJ
software.
Quantification of Plasma Soluble JAM-C
sJAM-C plasma content was analyzed by ELISA.
Cytokine and Chemokine Expression Profile
The profile of different inflammatory mediators in mouse cremasters was
analyzed using the Mouse Cytokine Array Panel A Array Kit or ELISA kits.
1084 Immunity 42, 1075–1086, June 16, 2015 ª2015 The Authors
In Vitro Digestion of JAM-C
Purified recombinant murine JAM-C was incubated with purified NE for 1 hr at
37. Samples were then resolved in a SDS-PAGE gel and visualized by West-
ern blot.
Co-immunoprecipitation
Bonemarrow (BM)-derived neutrophils were purified and stimulated with LTB4
or left unstimulated. Samples were then lysed, incubated overnight with an
anti-Mac-1 mAb, and immunoprecipitated. JAM-C and NE protein content
was then analyzed by Western blot.
Immunoblot
Samples were resolved on SDS-PAGE gels and electrotransferred onto PVDF
membranes. These were then blocked, incubated with primary and HRP-con-
jugated secondary antibodies, and developed using a Chemoluminescent
Substrate.
In Vitro Neutrophil Adhesion Assay
16-well glass chamber slides were coated with recombinant human ICAM-1
and blocked with 10% BSA. BM Neutrophils (5 3 104/well) were added to
the chambers and were either left untreated or stimulated with LTB4. In
some experiments, neutrophils were pre-incubated with an anti-Mac-1 mAb.
The number of adherent cells was quantified by phase contrast microscopy.
Imaging of JAM-C Cleavage In Vitro
BM neutrophils seeded in 16-well glass chamber slides coated with recombi-
nant ICAM-1 and JAM-C were left untreated or stimulated with LTB4, LTB4+
GW311616A or KC for 30 min. Slides were then fixed, immunostained with an-
tibodies against JAM-C and MRP-14, and analyzed by confocal microscopy.
In Vivo NE Enzymatic Activity Assay
NE680FAST was injected i.v. and left to circulate for 15min before induction of
inflammation. At the end of the experiment tissues were collected, immuno-
fluorescently stained, and analyzed by confocal microscopy.
In Vitro NE Enzymatic Activity Assay
BM neutrophils were seeded on ICAM-1 and JAM-C coated slides and left
untreated or stimulated for 30 min with KC or LTB4 in the presence of NE680-
FAST. Slides were then washed, fixed, immunostained, and analyzed by
confocal microscopy.
Confocal Intravital Microscopy of Mouse Cremaster Muscles
Lyz2-EGFP-ki mice were injected (i.s.) with Alexa-555-PECAM-1 to stain EC
junctions of the cremaster microvasculature. After cremaster exteriorization,
postcapillary venules were selected for in vivo analysis of leukocyte-vessel
wall interactions.
Analysis of Lung Neutrophil Infiltration
Following perfusion of pulmonary vasculature, lungs were excised and
digested. The resulting cells were stained and the number of neutrophils
analyzed by flow cytometry.
Flow Cytometry
Samples were immunostained with fluorescently conjugated antibodies.
Following red blood cell lysis, samples were run on a flow cytometer and
analyzed using Flowjo software (TreeStar).
Measurement of Tissue Plasma Extravasation
Evans blue solution was injected i.v. and allowed to circulate for 10 min before
mice were killed. Following vascular wash-out, tissues were collected and the
accumulated Evans blue (tissue albumin) was quantified as a measure of
plasma leakage.
Statistics
Data analysis was performed using the statistical software GraphPad Prism 4.
Results are expressed as mean ± SEM. Statistical significances were
assessed by Student’s t test, chi-square test, one-way ANOVA with Student-
Newman-Keuls multiple comparison test, or two-way ANOVA with Bonferroni
post hoc test as appropriate. Correlations were quantified by Pearson’s corre-
lation coefficient. p < 0.05 were considered significant.
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